Skip to main content
. 2018 Mar 22;10(3):e2360. doi: 10.7759/cureus.2360

Figure 3. Initial, Boost, and Sum Plans.

Figure 3

The top row presents isodose curves for the 66 Gy initial prostatic fossa salvage radiotherapy plan, delivered with a NovalisTX (BrainLAB AG, Feldkirchen, Germany) linear accelerator. The middle row presents the isodose curves of the 12 Gy boost plan, delivered with the ViewRay (ViewRay, Inc., Cleveland, OH, USA) system. The bottom presents the sum total isodose curves overlaid on the ViewRay system simulation scan. The isodose line legend is featured in the middle panel of each row.